Breathe Well Live Well
|
PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023 …
Medgadget.com (blog) The Report PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz. Asthma accounts for … |
View full post on asthma – Google News
|
Glaxo submits new asthma drug application in Japan
MarketWatch LONDON–Pharmaceutical company GlaxoSmithKline PLC (GSK.LN) said Friday it has submitted a new drug application to the Japanese health ministry for mepolizumab, a drug used for treating a type of severe asthma. The application for mepolizumab has … Glaxo Submits Japan Application For Mepolizumab In Eosinophilic Asthma |
View full post on asthma – Google News
|
PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023
MarketWatch Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with … |
View full post on asthma – Google News
|
Asthma Drug Market 2023 Forecasts: US, 5EU & Japan Industry Analysis
MarketWatch According to Asthma – 5EU Drug Forecast and Market Analysis to 2023 research report covering the UK, France, Italy, Spain, Germany, the 2013 base-year market sales of asthma products in France were $918m.The relatively slow growth of the German … Fostair Asthma Market Forecast Analysis in recent report |
View full post on asthma – Google News
|
Research and Markets: Japan Asthma Market Report 2014-2019
The Herald | HeraldOnline.com (press release) The research includes Japan asthma market size estimates for 2013, market share forecast for six years to 2019, asthma drugs market share, asthma drugs sales estimates, asthma drugs sales forecast, and asthma late stage pipeline products. This research … |
View full post on asthma – Google News
|
Tsukuba team uncovers asthma-intestine mechanism
The Japan Times A team of researchers from the University of Tsukuba in Ibaraki Prefecture has found a mechanism in which bad bacteria within mice intestines exacerbates asthma, fueling hope it can lead to a treatment for asthma in humans. The team, headed by Akira … |
View full post on asthma – Google News
|
Relvar Ellipta Approved in Japan for Treatment of Asthma
Benzinga GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved RELVAR™ ELLIPTA™ for the treatment of bronchial asthma (in cases where … GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma … Double asthma approval in Japan lifts SkyePharma Asthma drugs head Japan approvals |
View full post on asthma – Google News
|
Asthma Drug Relva Approved In Europe, Japan, But Not The United States
The Inquisitr The United States has already approved the new Asthma drug but it's marketed as Breo in the United States. But US doctors are only allowed to prescribe Breo for chronic obstructive pulmonary disease (COPD) while Europe is recommending the new drug for … Relvar Ellipta Approved in Japan for Treatment of Asthma GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma … Double asthma approval in Japan lifts SkyePharma |
View full post on asthma – Google News
|
GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma …
RTT News GlaxoSmithKline plc(GSK: Quote,GSK.L), and Theravance, Inc.(THRX: Quote), Friday said that Relvar Ellipta for the treatment of bronchial asthma got approval from the Japanese Ministry of Health, Labour and Welfare. The company said Relvar Ellipta is … Japan approves lung drugs from GSK/Theravance and SkyePharma Glaxo's Relvar Lung Treatment Recommended by EU Regulator GlaxoSmithKline Treatments Given Positive Opinion In Europe, Approved in Japan |
View full post on asthma – Google News
Science World Report |
Mutations linked to allergies, asthma
The Japan Times WASHINGTON – U.S. scientists said Wednesday they have found a genetic link to allergies as well as certain connective tissue disorders. The findings in the journal Science Translational Medicine show that a single genetic pathway may open the door to … Faulty TGF-beta Genetic Pathway Implicated As The Root Of Allergies Scientists Uncover Genetic Glitch Responsible for Allergies |
View full post on asthma – Google News